Search

everythinglearnresearchcommunity

for

Search:↓

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Patients chose Chinese herbal medicine for safety, relapse prevention, and as an alternative to conventional treatments, but found preparation burdensome.

A girl with a rare syndrome had successful hair loss treatment with no relapse after 4 years.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

The conclusion is that surgical removal of solitary fibrofolliculoma is effective with no relapses, and diagnosis requires a biopsy due to varied symptoms.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Follicular unit extraction successfully restored hair growth in a leprosy patient without disease relapse.

New biomarkers and targets for breast cancer treatment were identified to help prevent relapse and metastasis.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

Combining nonablative fractional laser with minoxidil was effective for alopecia areata with only one patient relapsing after a year.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Platelet-Rich Plasma treatment has limited and temporary effects on severe Alopecia Areata and does not prevent relapses.

Face transplant for a severe autoimmune disease patient was successful, improving appearance and function without disease relapse after three years.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

A dog with complete hair loss regrew most hair after treatment, with no relapse after stopping treatment.

Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

The cat's skin condition improved significantly with medication, with no relapse.